The next pope will have the weight of the world’s 1.4 billion Catholics on his shoulders. That’s how the Rev. Daniel Carr, 40 ...

A record entirely from the South, in a sector that has always been a thorn in the side. At the University Hospital of Palermo ...

NT219, a novel dual inhibitor of IRS1/2 and STAT3, is being evaluated in a Phase 2 study in patients with recurrent and/or ...

The predominant narrative trajectory concerning Lakota historiography, as articulated by non-Lakotas, generally follows this ...

(NASDAQ: REGN) today announced that the European Commission (EC) has granted conditional marketing approval of Lynozyfic™ (linvoseltamab) to treat adults with relapsed and refractory (R/R) multiple ...

Approval of Lynozyfic is based on data showing deep and durable responses in relapsed/refractory multiple myeloma Lynozyfic will provide a new option with convenient dosing and administration to patie ...

Although confirmatory animal studies demonstrating the extent of IgG2 dimerization are not yet available, the special features of IgG4 and IgG2 remind us that natural selection has generated four ...

However, all of those places will have additional competition to land him. "He's among our top five rated uncommitted players in the portal as of Wednesday and will be a hot commodity." ...

The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing. Ben Hargreaves ...

Shrinking season 3 needs to give more screen time to these brilliant characters so that their storylines and individual journeys are explored.